<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20241109063649N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-08-02</date_registration>
      <primary_sponsor>Ilam University of Medical Sciences</primary_sponsor>
      <public_title>"How Supportive Education Can Help Heart Attack Patients Manage Anxiety and Cope Better: A Study Based on the Neuman Systems Model."</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Supportive Education Based on the Neuman Systems Model on Anxiety Levels and Coping Strategies in Patients with Myocardial Infarction</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-08-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/82002</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Other design features: This RCT at Mostafa Khomeini Hospital will enroll 70 MI patients randomized via block randomization (using permuted block randomization on block size=4) to intervention or control groups. Blinding will be applied to the outcome assessors who will evaluate anxiety and coping strategy outcomes. Data will also be analyzed by an independent researcher unaware of group assignments, Randomization description: Samples will be selected using an accessible sampling method and divided into test and control groups through permuted block randomization with blocks of four. The blocks include the following sequences: 1. IICC, 2. ICIC, 3. ICCI, 4. CCII, 5. CICI, and 6. CIIC, where the letter 'I' represents 'Intervention' (training) and the letter 'C' represents 'Control.' To conceal the generated sequences, six identical envelopes will be prepared, each containing a block of four letters (either 'C' or 'I'). These envelopes will be placed in identical packets. The first patient will then be asked to randomly select one of these six envelopes. Once the envelope is chosen by the individual, it will be opened, and the four-letter sequence inside will be recorded. This sequence will determine the order of the first four participants, with the individual being assigned the first to fourth positions based on randomization. The envelope will then be resealed and removed from the set until the remaining five envelopes are selected and the process is completed. The fifth patient will again be given the remaining envelopes to randomly select one, determining the sequence for the next set of participants. This method will be repeated for all samples to ensure proper randomization, Blinding description: Blinding will be applied to the outcome assessors who will evaluate anxiety and coping strategy outcomes. Data will also be analyzed by an independent researcher unaware of group assignments.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Myocardial Infarction. Condition 2: Generalized anxiety disorder.</hc_freetext>
      <i_freetext>Intervention 1: Participants in the intervention group will receive supportive education based on the Neuman Systems Model over a period of 12 weeks. The program includes a total of 12 sessions: one introductory session for assessment and interview,  three structured educational sessions focusing on anxiety, defense mechanisms, family support, and stress coping strategies, eight follow-up supportive sessions tailored to the individual needs of the participants. Sessions 1 and 12 will be conducted in person in the hospital’s educational room, while sessions 2–11 will be held remotely through online messaging platforms (e.g., WhatsApp, Telegram) or via telephon. Intervention 2: Control group: Participants in the control group will not receive any structured educational intervention. They will receive routine post-discharge care provided by the hospital, including standard clinical follow-up and general informational pamphlets about heart health from the cardiology unit. No specific training or supportive sessions will be provided to this group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is "The study involves participant information, and ethical approval does not permit the sharing of individual participant data, even in deidentified form. There is no further information."</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sanaz Aazami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Banganjab, Boulevard-e Pajoohesh, Ilam University of Medical Sciences Campus, ilam, iran</address>
        <city>ilam</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6931346186</zip>
        <telephone>+98 84 3222 3083</telephone>
        <email>aazamisanaz@gmail.com</email>
        <affiliation>Ilam University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sanaz Aazami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Banganjab, Boulevard-e Pajoohesh, Ilam University of Medical Sciences Campus, ilam, iran</address>
        <city>Banganjab, Boulevard-e Pajoohesh, Ilam University of Medical Sciences Campus, ilam, iran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6931346186</zip>
        <telephone>+98 84 3222 3083</telephone>
        <email>aazamisanaz@gmail.com</email>
        <affiliation>Ilam University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Diagnosis of myocardial infarction (MI) by the treating physician
age between 35 and 70 years
no known psychotic disorders
No acute pain
ejection fraction (EF) above 30%
Have access to online messaging services</inclusion_criteria>
      <agemin>35 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>unwillingness to continue participation
incomplete questionnaire responses
development of another cardiac condition or deterioration of the patient's health for any reason that increases anxiety
absence more than one educational session.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I21</hc_code>
      <hc_code>F41.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction</hc_keyword>
      <hc_keyword>Generalized anxiety disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Participants in the intervention group will receive supportive education based on the Neuman Systems Model over a period of 12 weeks. The program includes a total of 12 sessions: one introductory session for assessment and interview,  three structured educational sessions focusing on anxiety, defense mechanisms, family support, and stress coping strategies, eight follow-up supportive sessions tailored to the individual needs of the participants. Sessions 1 and 12 will be conducted in person in the hospital’s educational room, while sessions 2–11 will be held remotely through online messaging platforms (e.g., WhatsApp, Telegram) or via telephon</i_keyword>
      <i_keyword>Control group: Participants in the control group will not receive any structured educational intervention. They will receive routine post-discharge care provided by the hospital, including standard clinical follow-up and general informational pamphlets about heart health from the cardiology unit. No specific training or supportive sessions will be provided to this group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Coping strategy. Timepoint: 3 months. Method of measurement: Lazarus and Folkman Coping Strategies Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ilam University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-12-24</approval_date>
        <contact_name>ethic committee of ilam university of medical sciences</contact_name>
        <contact_address>Ilam, Banganjab, Boulevard-e Pajoohesh, Campus of Ilam University of Medical Sciences Ilam Ilam Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
